Structurally targeted mutagenesis identifies key residues supporting -synuclein misfolding in multiple system atrophy

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Multiple system atrophy (MSA) and Parkinson's disease (PD) are neurodegenerative disorders characterized by misfolded alpha-synuclein.
• While PD has known genetic links, MSA lacks identified mutations, suggesting distinct alpha-synuclein strains.

Purpose of the Study:

• To identify key residues involved in alpha-synuclein misfolding specific to MSA.
• To investigate the mechanism by which the PD-linked E46K mutation inhibits MSA prion replication.

Main Methods:

• Engineered cell lines with PD-linked and novel alpha-synuclein mutations.
• Utilized in silico analyses with Maestro software to predict mutation effects.
• Determined the mechanism of E46K inhibition using cellular models.

Main Results:

• Successfully identified mutations influencing alpha-synuclein misfolding in MSA.
• Computational modeling partially predicted mutation effects, highlighting challenges with intrinsically disordered proteins.
• Discovered that the E46/K80 salt bridge is crucial for supporting alpha-synuclein misfolding in MSA.

Conclusions:

• Developed a powerful panel of cell lines for interrogating MSA strain biology.
• Provided insights into the structural basis of alpha-synuclein misfolding in neurodegenerative diseases.
• Demonstrated the utility and limitations of computational tools in studying protein misfolding.